Cargando…

Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin

Empagliflozin (EMPA) is a sodium–glucose transporter 2 (SGLT2) inhibitor that functions as a new-generation glucose-lowering agent and has been proven to be beneficial for patients with cardiovascular diseases. However, the possible benefits and mechanisms of its antiarrhythmic effects in cardiac ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jhuo, Shih-Jie, Liu, I-Hsin, Tasi, Wei-Chung, Chou, Te-Wu, Lin, Yi-Hsiung, Wu, Bin-Nan, Lee, Kun-Tai, Lai, Wen-Ter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200966/ https://www.ncbi.nlm.nih.gov/pubmed/34198942 http://dx.doi.org/10.3390/ijms22116105

Ejemplares similares

Effects of Secretome from Fat Tissues on Ion Currents of Cardiomyocyte Modulated by Sodium-Glucose Transporter 2 Inhibitor
por: Jhuo, Shih-Jie, et al.
Publicado: (2020)

Effects of Trans, Trans-2,4-decadienal on the Ions Currents of Cardiomyocytes: Possible Mechanisms of Arrhythmogenesis Induced by Cooking-oil Fumes
por: Jhuo, Shih-Jie, et al.
Publicado: (2020)

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling
por: Jhuo, Shih-Jie, et al.
Publicado: (2023)

Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension
por: Jhuo, Shih-Jie, et al.
Publicado: (2022)

Characteristics of diurnal ventricular premature complex variation in right ventricular outflow tract arrhythmias after catheter ablation
por: Jhuo, Shih-Jie, et al.
Publicado: (2017)

The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
por: Lee, Hsiang-Chun, et al.
Publicado: (2019)

Association of Increased Arterial Stiffness and P Wave Dispersion with Left Ventricular Diastolic Dysfunction
por: Tsai, Wei-Chung, et al.
Publicado: (2013)

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
por: Puar, Pankaj, et al.
Publicado: (2023)

Sodium–Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice
por: Xue, Genlong, et al.
Publicado: (2022)

Distinctive electrophysiological characteristics of right ventricular out-flow tract cardiomyocytes
por: Lu, Yen-Yu, et al.
Publicado: (2014)

Evaluation of a real-time magnetic resonance imaging-guided electrophysiology system for structural and electrophysiological ventricular tachycardia substrate assessment
por: Mukherjee, Rahul K, et al.
Publicado: (2019)

An electrophysiological substrate of COVID-19
por: Tereshchenko, Larisa G., et al.
Publicado: (2023)

Impact of diabetes duration on left ventricular mass regression with empagliflozin
por: Moroney, Michael, et al.
Publicado: (2023)

A novel noninvasive surface ECG analysis using interlead QRS dispersion in arrhythmogenic right ventricular cardiomyopathy
por: Hsieh, Wan-Hsin, et al.
Publicado: (2017)

Radiofrequency catheter ablation of the left ventricular epicardium as an electrophysiological substrate in a patient with idiopathic ventricular fibrillation associated with early repolarization
por: Nakajima, Ikutaro, et al.
Publicado: (2023)

Healthcare resource utilization in patients treated with empagliflozin in East Asia
por: Sheu, Wayne H‐H, et al.
Publicado: (2022)

Electrophysiological Substrate in Patients with Barlow’s Disease
por: Vergara, Pasquale, et al.
Publicado: (2021)

Impact of Obesity on Atrial Electrophysiological Substrate
por: Schram Serban, Corina, et al.
Publicado: (2023)

Areca Nut Chewing and Risk of Atrial Fibrillation in Taiwanese Men: A Nationwide Ecological Study
por: Tsai, Wei-Chung, et al.
Publicado: (2013)

Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study
por: Tsai, Wei-Chung, et al.
Publicado: (2016)

Fabrication of Inorganic Coatings Incorporated with Functionalized Graphene Oxide Nanosheets for Improving Fire Retardancy of Wooden Substrates
por: Tasi, Tsung-Pin, et al.
Publicado: (2022)

Electrophysiological ventricular substrate of stroke: a prospective cohort study in the Atherosclerosis Risk in Communities (ARIC) study
por: Johnson, John A, et al.
Publicado: (2021)

Clinical significance of structural remodeling concerning substrate characteristics and outcomes in arrhythmogenic right ventricular cardiomyopathy
por: Lin, Chin-Yu, et al.
Publicado: (2022)

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Characterization of ARVC substrate on MRI and electrophysiological mapping
por: Clement-Guinaudeau, Stephanie, et al.
Publicado: (2016)

Electrophysiological Mechanisms of Ventricular Fibrillation Induction
por: Chattipakorn, Nipon, et al.
Publicado: (2005)

Empagliflozin: a potential anticancer drug
por: Wu, Wenwen, et al.
Publicado: (2023)

Empagliflozin reduces Ca/calmodulin‐dependent kinase II activity in isolated ventricular cardiomyocytes
por: Mustroph, Julian, et al.
Publicado: (2018)

Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes
por: Sarak, Bradley, et al.
Publicado: (2021)

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
por: Butler, Javed, et al.
Publicado: (2021)

Association of Arterial Stiffness and Electrocardiography-Determined Left Ventricular Hypertrophy with Left Ventricular Diastolic Dysfunction
por: Hsu, Po-Chao, et al.
Publicado: (2012)

Electrocardiographic and Electrophysiologic Characteristics of Ventricular Extrasystoles Arising from the Aortomitral Continuity
por: Letsas, Konstantinos P., et al.
Publicado: (2011)

Clinical and electrophysiological characteristics of ventricular arrhythmias arising from pulmonary cusps
por: Rangaswamy, Vickram V., et al.
Publicado: (2020)

Percutaneous Pulmonary Valve Implantation Alters Electrophysiologic Substrate
por: Nguyen, Hoang H., et al.
Publicado: (2016)

Electrophysiological characteristics and long-term outcome of substrate-based catheter ablation for left posterior fascicular ventricular tachycardia targeting fragmented antegrade Purkinje potentials during sinus rhythm
por: Wei, Hui-Qiang, et al.
Publicado: (2023)

Electrophysiology of human cardiac atrial and ventricular telocytes
por: Sheng, Jingwei, et al.
Publicado: (2014)

Local late gadolinium enhancement features to identify the electrophysiological substrate of post-infarction ventricular tachycardia: a machine learning approach
por: Lozoya, Rocio Cabrera, et al.
Publicado: (2015)

Electrocardiographic and electrophysiological characteristics of idiopathic ventricular arrhythmias with acute successful ablation at the superior portion of the mitral annulus
por: Di, Chengye, et al.
Publicado: (2021)

The Different Substrate Characteristics of Arrhythmogenic Triggers in Idiopathic Right Ventricular Outflow Tract Tachycardia and Arrhythmogenic Right Ventricular Dysplasia: New Insight from Noncontact Mapping
por: Do, Van Buu Dan, et al.
Publicado: (2015)

Effects of ivabradine on ventricular electrophysiological remodeling after myocardial infarction in rats
por: Jiang, Li-ping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r9b607ljb5mrjqtbtgvt24f7rs